FDA Issues Warning About Design Flaw in Medtronic Drug Pump

A serious design defect has shown up in The Medtronic drug pump intended to deliver drugs to victims of chronic pain and spasms.

This device delivers drugs directly into the spinal fluid as a way to treat chronic pain and spasticity.

Discovery of HCN2 Gene may Pave the Way for Better Chronic Pain Management
Chronic pain poses a huge challenge to treat, but the recent discovery of a gene which regulates prolonged pain, can actually be a blessing in the treatment of chronic pain.

The malfunction in the pump has caused interruptions in the delivery of the drugs which has prompted the FDA to issue a class-one recall of this product.

SynchroMed II implantable pump models 8637-20 and 8637-40, distributed between 2004 and 2011 have faced the recall.

Patients have been advised to consult their doctor if they experience any symptoms or if the alarm inside the device goes off.

Chronic Pain More for Smokers Than Non-smokers
Smokers are more likely to report problems with persistent musculoskeletal pain than non-smokers, a new study has found.

Source-Medindia

J&J�s Drug for Chronic Pain Receives FDA Approval
The US Food and Drug Administration revealed that it has approved Johnson&Johnson’s tapentadol extended release drug, Nucynta ER

Chronic Pain Management Set to Get Better
Pain care management needs to be improved, with health care professionals committing to improve care as well as a retooling of the health care system to help people who are suffering,